Dabirom
Composition: Dabigatran Etexilate 75 mg & 110 mg Capsules
Marketing Division: Spectra Healthcare-Rojo
Description:
Dabirom belongs to the class of Anti-coagulants.
Dabirom is indicated in:
- Prevention of stroke and systemic embolism in patients with non-valvular atrial fibrillation.
- Treatment of Deep Vein Thrombosis (DVT) and Pulmonary Embolism (PE), and prevention of recurrent DVT & PE.
- Primary prevention of DVT & PE following elective total hip replacement or knee replacement surgery.
